Skip to main content
. 2018 Oct 4;9:1021. doi: 10.3389/fphar.2018.01021

Figure 3.

Figure 3

Effects of the pretreatment with anti-IL17 on BALF. (A) Total cells, (B) cell differential for macrophages, (C) cell differential for neutrophils, (D) cell differential for Lymphocytes, and (E) cell differential for eosinophils. The results are expressed as x104 cells/mL.*P < 0.05 compared to the SAL and SAL-antiIL17 groups; **P < 0.05 compared to the LPS group.